Particle.news
Business ❯ Corporate Governance ❯ Regulatory Compliance
False Claims Act Disclosure Obligations Investor Protection SEC Filings SEBI SEC Investigations TSX Venture Exchange Short Selling Prospectus Supplement Investor Relations
The deal aims to raise about $258.9 million, including a Goldman Sachs–affiliated private placement, to fund mid‑stage CNS trials.
